Research demonstrates that this medication reduces viral load, lung index, and serum IL-6 levels in mice with influenza-induced pneumonia, and effectively ameliorates the pathological damage to lung tissues caused by the virus (Sun et al., 2022). This evidence concerns the gene IL6 and influenza.